OCTP — Oxford Cannabinoid Technologies Holdings Share News
0.000.00%
Oxford Cannabinoid - Half-year Report
Oxford Cannabinoid - Notice of Results
Brief: Oxford Cannabinoid Technologies Holdings Files European Application In Its Own Name
Oxford Cannabinoid - Patent Applications
Oxford Cannabinoid - Directorate Appointment
Oxford Cannabinoid - TR-1: Notification of major holdings
Oxford Cannabinoid - TR-1: Notification of major holdings
Oxford Cannabinoid - Director Dealing
UK's Oxford Cannabinoid gains on positive update from drug trial
Brief: Oxford Cannabinoid Technologies Final Dose Of OCT461201 Administered
Oxford Cannabinoid - Notice of AGM
UK's Oxford Cannabinoid plummets as FY loss per share widens
Brief: Oxford Cannabinoid Says Lead Drug Candidate Poised To Complete Phase I Clinical Trial In Q3 2023
Oxford Cannabinoid - 2023 Final Results
Oxford Cannabinoid - Notice of Results
Brief: Oxford Cannabinoid Technologies Says First Dose Administered In Phase I Clinical Trial For Lead Drug Candidate OCT461201
Oxford Cannabinoid - Director/PDMR Share Purchases
RCS - Oxford Cannabinoid - Investor Presentation and Q&A – Programmes update
RCS - Oxford Cannabinoid - OCTP update from Doceo